系统性红斑狼疮与类风湿关节炎住院患者中股骨头坏死的趋势及相关关节置换术
基于美国全国住院患者样本(NIS)2000-2019年的横断面研究,分析42,728例(1.3%)SLE和43,600例(0.5%)RA住院合并股骨头坏死(AVN)的病例。SLE-AVN在2011年出现拐点(2000-2011年APC 1.94*,2011-2019年APC -2.03),RA-AVN总体上升(APC 0.98*),而两类患者AVN相关关节置换术均下降(SLE APC -2.03*,RA APC -0.82*)。黑人种族和医疗补助覆盖者接受关节置换术的可能性较低,提示潜在差异。
要点
- SLE-AVN在2011年后出现拐点,APC由1.94*转为-2.03。
- RA-AVN总体增加(APC 0.98*),但相关关节置换术减少(APC -0.82*)。
- 黑人种族和医疗补助覆盖者接受AVN相关关节置换术的可能性较低。
核心结论
- SLE-AVN在2011年后出现上升拐点,可能与新型保激素疗法(如贝利尤单抗)有关。
- SLE和RA中AVN相关关节置换术均减少。
- 黑人患者和医疗补助覆盖者AVN相关关节置换术较少,提示潜在差异。
- 作者建议进一步研究应检查影响AVN和关节置换术率的治疗差异。
研究设计与样本
- 横断面研究,使用美国全国住院患者样本(NIS)2000-2019年数据。
- 通过ICD编码识别住院成人SLE和RA患者,伴或不伴AVN,AVN按关节置换状态分组。
- 主要结局为SLE和RA中AVN及AVN相关关节置换术的发生率和时间趋势。
- 使用STATA和Joinpoint回归计算年度百分比变化(APC)。
主要发现
- 总体42,728例(1.3%)SLE住院和43,600例(0.5%)RA住院合并AVN(SLE-AVN和RA-AVN)。
- 其中SLE-AVN有16,724例(39%)接受关节置换术,RA-AVN有25,210例(58%)接受关节置换术。
- RA-AVN增加(APC 0.98*),关节置换术减少(APC -0.82*)。
- SLE-AVN在2011年出现拐点(2000-2011年APC 1.94*,2011-2019年APC -2.03),关节置换术下降(APC -2.03*)。
- AVN住院患者较年轻且为黑人种族;黑人种族或医疗补助覆盖者接受关节置换术的可能性较低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者建议进一步研究应检查影响AVN和关节置换术率的治疗差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Avascular necrosis (AVN) is a devastating complication often necessitating arthroplasty, particularly common in systemic lupus erythematosus (SLE). Limited research exists on arthroplasty trends since new steroid-sparing agents. We analyzed trends and characteristics associated with AVN and AVN-related arthroplasties among SLE and RA hospitalizations using two decades of data from the U.S. National Inpatient Sample (NIS). METHODS: This cross-sectional study used NIS (2000-2019) to identify hospitalized adults with SLE and RA, with or without AVN, using ICD codes. AVN was further grouped by arthroplasty status. Primary outcomes were AVN and AVN-related arthroplasty rates and time trends in SLE and RA. Baseline sociodemographics and comorbidities were compared. Analyses used STATA and Joinpoint regression to calculate annual percent change (APC). RESULTS: Overall, 42,728 (1.3 %) SLE and 43,600 (0.5 %) RA hospitalizations had concomitant AVN (SLE-AVN and RA-AVN). Of these, 16,724 (39 %) and 25,210 (58 %) underwent arthroplasties, respectively. RA-AVN increased (APC: 0.98*), with a decrease in arthroplasties (APC: -0.82*). In contrast, SLE-AVN initially increased with a breakpoint in 2011 (APC 2000-2011: 1.94* APC 2011-2019 -2.03), with declining arthroplasties (APC -2.03*). AVN hospitalizations consisted of individuals who were younger and of Black race; while arthroplasties were less likely in individuals of Black race or Medicaid coverage. CONCLUSION: We report a breakpoint in rising SLE-AVN after 2011, which may relate to newer steroid-sparing therapies (i.e., belimumab). AVN-associated arthroplasties decreased in SLE and RA. Fewer AVN-associated arthroplasties were noted for Black patients and those with Medicaid, indicating potential disparities. Further research should examine treatment differences impacting AVN and arthroplasty rates.
引用
- Dhital R, Singh NC, Spiker AM, et al. Trends in avascular necrosis and related arthroplasties in hospitalized patients with systemic lupus erythematosus and rheumatoid arthritis. Semin Arthritis Rheum. 2024. PMID: 38604118. doi:10.1016/j.semarthrit.2024.152444
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。